DFSVX
Price
$48.52
Change
-$0.67 (-1.36%)
Updated
Sep 20 closing price
JSVQX
Price
$29.65
Change
-$0.42 (-1.40%)
Updated
Sep 20 closing price
Ad is loading...

DFSVX vs JSVQX

Header iconDFSVX vs JSVQX Comparison
Open Charts DFSVX vs JSVQXBanner chart's image
DFA US Small Cap Value I
Price$48.52
Change-$0.67 (-1.36%)
VolumeN/A
CapitalizationN/A
JPMorgan Small Cap Value R4
Price$29.65
Change-$0.42 (-1.40%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DFSVX vs JSVQX Comparison Chart
Loading...
VS
DFSVX vs. JSVQX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and JSVQX is a StrongBuy.

FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 16.7B vs. JSVQX (1.36B). DFSVX pays higher dividends than JSVQX: DFSVX (1.44) vs JSVQX (1.26). DFSVX was incepted earlier than JSVQX: DFSVX (32 years) vs JSVQX (8 years). JSVQX is a more actively managed with annual turnover of: 79.00 vs. DFSVX (25.00). DFSVX (0) and JSVQX (0) have matching initial minimum investment requirements. JSVQX annual gain was more profitable for investors over the last year : 26.20 vs. DFSVX (22.84). DFSVX return over 5 years is better than : 55.21 vs. JSVQX (20.68).
DFSVXJSVQXDFSVX / JSVQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years8 years-
Gain YTD8.78810.46984%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets16.7B1.36B1,227%
Annual Yield % from dividends1.441.26114%
Returns for 1 year22.8426.2087%
Returns for 3 years17.09-7.66-223%
Returns for 5 years55.2120.68267%
Returns for 10 years44.49N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHVN40.39-0.03
-0.07%
Biohaven Ltd
FNA6.87-0.01
-0.15%
Paragon 28
GIB112.76-1.07
-0.94%
CGI
CMPX1.68-0.05
-2.89%
Compass Therapeutics
CPIX1.24-0.04
-3.12%
Cumberland Pharmaceuticals